NYSE : MRK

Merck & Co., Inc.

$130.39 USD

-$1.43 (-1.08%)

Volume
5.14M
Average Volume
10.29M
Market Capitalization
$322.04B
P/E Ratio
36.63
Dividend Yield
2.58%
Price Target
$143.50
Year High
$135.05
Year Low
$77.53
Day High
—
Day Low
—
Payout Ratio
$0.92
Current Ratio
$1.30
Company Overview

NYSE

Robert Davis

Drug Manufacturers - General

Healthcare

MRK

75000

US

USD

https://www.merck.com

908 740 4000

58933Y105

0000310158

Liquidity Metrics

1.07

1.30

1.06

0.20

0.92

Sales & Valuation

$64.93B

4.91

7.03

22.82

5.71

Profitability

$7.28

$18.25B

13.62%

17.73%

17.93%

6.94%

P/E Metrics

36.63

-0.76

-0.76

Analyst Price Target & Rating

$143.50

$155.00

$105.00

Neutral

3/5

37 Analysts

-9.14%

Financial Health Scores

4.04

6/9

$8.07B

$128.68B

$82.75B

$12.67B

Key Metrics (TTM)

$369.4B

5.63

19.67

1.30

17.93%

13.34%

2.74%

4.33%

$38.85

128 days

Company Executives
Name Title
Richard R. DeLuca Jr. Executive Vice President & President of Merck Animal Health
Robert Davis Chairman, President & Chief Executive Officer
Betty D. Larson Executive Vice President & Chief Human Resources Officer
Chirfi Guindo Executive Vice President of Strategic Access, Policy & Communications
Caroline Litchfield Executive Vice President & Chief Financial Officer
Jennifer L. Zachary Executive Vice President & General Counsel
Dean Y. Li Executive Vice President & President of Merck Research Laboratories
David Michael Williams Executive Vice President and Chief Information & Digital Officer
Dalton E. Smart Senior Vice President of Finance, Principal Accounting Officer & Global Controller
Peter Dannenbaum Vice President of Investor Relations
Poll Results

No votes yet today — be the first to share your view!

About Merck & Co., Inc. (NYSE:MRK) Stock

Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, ... and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.

Merck Announces Fourth-Quarter 2026 Dividend

2026-07-29 12:00:00

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the Board of Directors has declared a quarterly dividend of $0.85

Merck Announces Fourth-Quarter 2026 Dividend

2026-07-29 11:04:00

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Announces Fourth-Quarter Dividend.

Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock

2026-07-29 10:01:05

Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Merck & Co., Inc. $MRK Shares Purchased by Arete Wealth Advisors LLC

2026-07-29 03:50:59

Arete Wealth Advisors LLC increased its position in shares of Merck and Co., Inc. (NYSE: MRK) by 30.8% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 51,371 shares of the company's stock after buying an additional 12,096 shares during the quarter. Arete

Earnings Preview: Merck (MRK) Q2 Earnings Expected to Decline

2026-07-28 11:07:10

Merck (MRK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Brokerages Set Merck & Co., Inc. (NYSE:MRK) Target Price at $133.94

2026-07-26 01:59:11

Merck and Co., Inc. (NYSE: MRK - Get Free Report) has earned an average rating of "Moderate Buy" from the twenty analysts that are presently covering the company, MarketBeat Ratings reports. Seven analysts have rated the stock with a hold rating, twelve have issued a buy rating and one has assigned a strong buy rating to

Bollard Group LLC Acquires 6,691 Shares of Merck & Co., Inc. $MRK

2026-07-25 03:57:51

Bollard Group LLC lifted its holdings in shares of Merck and Co., Inc. (NYSE: MRK) by 5.1% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 138,765 shares of the company's stock after acquiring an additional 6,691 shares during

Merck licenses experimental HIV pill to generic makers in 129 countries

2026-07-24 06:48:02

Merck said on Friday it signed seven voluntary licensing agreements with generic drug manufacturers to make and sell lower-cost versions ​of its experimental once-monthly oral HIV pill in 129 low- ‌and lower-middle-income countries.

Frequently Asked Questions

What is the current Merck & Co., Inc. (MRK) stock price?

Merck & Co., Inc.(NYSE:MRK) stock price is $130.39 in the last trading session. During the trading session, MRK stock reached the peak price of $135.05 while $77.53 was the lowest point it dropped to. The percentage change in MRK stock occurred in the recent session was --1.08% while the dollar amount for the price change in MRK stock was -$1.43.

MRK's industry and sector of operation?

The NYSE listed MRK is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector.

Who are the executives of MRK?

Richard R. DeLuca Jr. | Executive Vice President & President of Merck Animal Health
Robert Davis | Chairman, President & Chief Executive Officer
Betty D. Larson | Executive Vice President & Chief Human Resources Officer
Chirfi Guindo | Executive Vice President of Strategic Access, Policy & Communications
Caroline Litchfield | Executive Vice President & Chief Financial Officer

How many employees does MRK have?

Number of MRK employees currently stands at 75000. MRK operates from 126 East Lincoln Avenue, Rahway, NJ 07065, US.

Link for MRK official website?

Official Website of MRK is: https://www.merck.com

How do I contact MRK?

MRK could be contacted at phone #908 740 4000 and can also be accessed through its website. MRK operates from 126 East Lincoln Avenue, Rahway, NJ 07065, US.

How many shares of MRK are traded daily?

The average number of MRK shares traded daily for last 3 months was 10.29M.

What is the market cap of MRK currently?

The market value of MRK currently stands at $322.04B with its latest stock price at $130.39